key: cord-0751339-xi6zn0am authors: Brenner, H.; Holleczek, B.; Schoettker, B. title: Vitamin D insufficiency and deficiency and mortality from respiratory diseases in a cohort of older adults: potential for limiting the death toll during and beyond the COVID-19 pandemic date: 2020-06-23 journal: nan DOI: 10.1101/2020.06.22.20137299 sha: 2d577f7088c9d83698871c9d93534fd3df95e6f4 doc_id: 751339 cord_uid: xi6zn0am Background. The COVID-19 pandemic goes along with increased mortality from acute respiratory disease, and measures to limit the spread of the infection go along with increased risk of vitamin D deficiency, especially among high risk groups. It has been suggested that vitamin D3 supplementation might help to reduce respiratory disease mortality. Methods. We assessed the prevalence of vitamin D insufficiency and deficiency, defined by 25(OH)D blood levels of 30-50 and <30 nmol/L, respectively, and their association with mortality from respiratory diseases during 15 years of follow-up in a cohort of 9,548 adults aged 50-75 years from Saarland, Germany. Results. Vitamin D insufficiency and deficiency were common (44% and 15%, respectively). Compared to sufficient vitamin D status, respiratory disease mortality was 2.1 (95%-CI 1.3-3.2)- and 3.0 (95%-CI 1.8-5.2)-fold increased, respectively. Although significant increases were seen in both women and men, they were much stronger among women, with 8.5 (95% CI 2.4-30.1) and 2.3 (95% CI 1.1-4.4)-fold increase of respiratory disease mortality in case of vitamin D deficiency among women and men, respectively (p-value for interaction =0.041). Overall, 41% (95% CI 20%-58%) of respiratory disease mortality was statistically attributable to vitamin D insufficiency or deficiency. Conclusion. Vitamin D insufficiency and deficiency are common and account for a large proportion of respiratory disease mortality in older adults, supporting suggestions that vitamin D3 supplementation might make a major contribution to limit the burden of the COVID-19 pandemic, particularly among women. The Corona Virus Disease 2019 (COVID-19) pandemic goes along with strongly increased 26 respiratory disease mortality. It has been suggested that vitamin D3 supplementation could 27 be a potentially promising and safe approach to reduce risk of COVID-19 infections and 28 deaths (1). Meta-analyses of randomized clinical trials (RCTs) have shown that vitamin D3 29 supplementation reduces the risk of acute respiratory tract infections (2). Risk reduction with 30 regular (daily or weekly) supplementation of physiological doses of vitamin D was especially 31 strong (by 70%) among people with vitamin D deficiency, but significant risk reduction (by 32 25%) was also found among people with higher vitamin D levels. 33 People with pre-existing major diseases, such as diabetes or cancer are at increased risk of 34 dying from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. At the 35 same time, prevention of and care for these diseases have been and keep being strongly 36 compromised by current measures to limit the COVID-19 pandemic. Meta-analyses of clinical 37 trials have demonstrated that vitamin D3 supplementation has the potential to also reduce 38 cancer mortality by approximately 13% (3). 39 We previously assessed the prevalence of vitamin D insufficiency and deficiency and their 40 association with all-cause mortality and mortality from cardiovascular, cancer and respiratory 41 diseases in a cohort of 9,548 adults aged 50-75 years from Saarland, Germany (4-8). We 42 aim to present considerably updated and sex-specific follow-up data of 15 years here and to 43 calculate the proportion of respiratory disease mortality that is attributable to vitamin D 44 insufficiency and deficiency. Furthermore, we discuss potential implications for prevention in 45 the context of the ongoing COVID-19 pandemic. 46 47 48 49 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.22.20137299 doi: medRxiv preprint This investigation is based on the ESTHER study, an ongoing statewide cohort study from 52 Saarland, Germany, details of which have been reported elsewhere (4-9). Briefly, 9,940 men 53 and women, aged 50-75 years at baseline, were recruited by their general practitioners 54 during a routine health check-up between 2000 and 2002. Blood samples were taken at 55 baseline at the general practitioners' offices. Information on socio-demographic and lifestyle 56 characteristics and medical history were obtained by questionnaires from participants and 57 their general practitioners, and the distribution of those characteristics was similar to the 58 distribution in the respective age categories in the German National Health Survey 59 conducted in a representative sample of the German population in1998 (9). The ESTHER 60 study was approved by the ethics committees of the University of Heidelberg and the state 61 medical board of Saarland, Germany. Written informed consent was issued by all 62 participants. 63 Information on socio-demographic characteristics, lifestyle and diet were obtained by a 66 comprehensive self-administered questionnaire from the study participants at baseline. 67 Height and weight were assessed and documented on a standardized form by the general 68 practitioners during the health check-up. Furthermore, blood and urine samples were taken 69 during the health check-up, centrifuged, sent to the study center and stored at -80°C until 70 The most abundant and stable vitamin D metabolite in blood samples, 25-hydroxyvitamin D 72 (25(OH)D) levels was measured from stored serum samples taken at recruitment. The 73 laboratory methods used are described in detail elsewhere (4). In brief, 25(OH)D levels in 74 women were measured with the Diasorin-Liaison analyzer (Diasorin Inc., Stillwater, USA). 75 Analyses in men were conducted in the context of a separate research project several years 76 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.22.20137299 doi: medRxiv preprint later (when the Diasorin measurements were no longer offered) with IDS-iSYS 77 (Immunodiagnostic Systems GmbH, Frankfurt Main, Germany). Both immunoassays were 78 standardized retrospectively to the gold standard method liquid chromatography tandem-79 mass-spectrometry. 80 Deaths until end of 2016 were identified by inquiry at the residents' registration offices and 81 death certificates of deceased study participants were provided by local health authorities. 82 The leading cause of death with an ICD-10 code was available for 98.9% of deceased study 83 participants and was coded with ICD-10 codes R98-R99 "unknown cause of death" for 4.4% 84 of deceased participants. These individuals were not excluded and censored at the time of 85 death for cause specific mortality outcomes. 86 87 Participants of the ESTHER baseline examination (n = 9,940) were excluded from this 89 investigation if no blood sample was available (n = 368) or if they could not be followed-up for 90 mortality (n = 24), which resulted in a total sample size of n = 9,548 subjects for this analysis. 91 We used the US-American Institute of Medicine's cut-offs to define adequate vitamin D 92 status (> 50 nmol/L), vitamin D insufficiency (30-50 nmol/L) and vitamin D deficiency (< 30 93 nmol/L) (10). We assessed prevalences of vitamin D insufficiency and deficiency in the total 94 study population and according to age, sex, life-style factors and major diseases and tested 95 for differences between groups by χ²-test. 96 We compared all-cause, cardiovascular disease, cancer, and respiratory disease mortality 97 between subjects with vitamin D insufficiency or deficiency and subjects with adequate 98 25(OH)D levels and estimated hazard ratios (HR) with 95% confidence intervals (95%CI) by 99 multivariable Cox proportional hazards models. We used an age, sex and season adjusted 100 model and a full model that was adjusted for potential confounders, which are listed in Table 101 1. Additional adjustment for potential intermediates (cardiovascular disease, history of 102 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.22.20137299 doi: medRxiv preprint cancer, diabetes mellitus, hypertension, asthma, total serum cholesterol and serum c-103 reactive protein levels) did not lead to substantially different results (data not shown). Age 104 and BMI were modelled as continuous variables and all other variables were modelled with 105 the categories shown in Table 1 . Furthermore, sex-specific analyses were performed and 106 statistical tests on interaction were carried out. In addition, we estimated the population 107 attributable fraction (PAF) of respiratory disease mortality from the prevalences of vitamin D 108 insufficiency and deficiency and their associations with respiratory disease mortality, as 109 derived from our study. The PAF of mortality is the share of mortality in a population that is 110 statistically attributable to a risk factor and that could be avoided by entirely eliminating that 111 risk factor (here: vitamin D insufficiency or deficiency) (11). 112 Missing values for covariates ranged from 0% to 5.8% (for fish consumption). Missing (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.22.20137299 doi: medRxiv preprint The study population included 43.8% men, mean age was 62.1 years ( Table 1) Table 1 also provides a description of further characteristics of the 127 study population at baseline as well as prevalences of vitamin D insufficiency and deficiency 128 according to those characteristics. Both vitamin D insufficiency and deficiency were 129 statistically significantly more frequent among females, with higher age, BMI, in subjects with 130 low physical activity and those who consumed fish less than once per week. A seasonal 131 variation with higher prevalences in winter than in summer months was also observed. 132 Moreover, the prevalence of vitamin D deficiency was significantly higher among current 133 smokers. and 1.7 [1.5-1.9], respectively) ( Table 2) . Vitamin D deficiency was also associated with 138 significant increases in CVD and cancer mortality by 52% and 38%, respectively (full model 139 results). However, vitamin D insufficiency and deficiency were particularly strongly 140 associated with respiratory disease mortality with full model HRs of 2.1 (95%CI: 1.3-3.2) and Table 3 shows the results of the sex-specific analyses. For all-cause, cardiovascular disease 145 and cancer mortality, only modest, statistically non-significant differences were seen between 146 women and men. Although significant increases were seen for respiratory disease mortality 147 in both women and men, they were much stronger among women, with 8.5 (95% CI 2.4-148 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.22.20137299 doi: medRxiv preprint 30.1) and 2.3 (95% CI 1.1-4.4)-fold increase of respiratory disease mortality in case of 149 vitamin D deficiency among women and men, respectively (p-value for interaction =0.024). 150 151 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.22.20137299 doi: medRxiv preprint In this large population-based cohort study from Saarland, Germany, the majority of 153 participants aged 50-75 years at baseline had vitamin D insufficiency or deficiency, and 154 these conditions were associated with increased mortality. In particular, mortality from 155 respiratory diseases was 2.1-and 3.0-fold increased in subjects with vitamin D insufficiency 156 or deficiency, respectively, compared to participants with sufficient vitamin D status. 157 Significant associations with respiratory disease mortality were seen among both women and 158 men, but they were particularly strong for women. Overall, 41% of deaths from respiratory 159 diseases were statistically attributable to vitamin D insufficiency or deficiency, and could 160 possibly be avoided by overcoming these conditions assuming causality of the association. 161 The assumption of causality of vitamin D3 effects on mortality obviously requires most careful 162 discussion. Although we made the best attempts to adjust potential confounding factors in 163 our analyses, the major limitation of our study is that we cannot exclude the possibility of 164 residual confounding by imperfect measurement of confounding variables, such as smoking 165 or physical activity, or omission of unknown confounders in this observational study. As 166 addressed in detail elsewhere (6), interpretation of the evidence is further complicated by the 167 fact that vitamin D deficiency could be considered both a consequence of poor health as well 168 as a risk factor for increased vulnerability to acute disease and poor outcomes of chronic 169 diseases among people with poor health. It is therefore paramount to critically evaluate our 170 findings in the light of additional criteria and evidence, such as biological mechanisms and 171 plausibility, and, in particular, in the light of data from RCTs providing vitamin D3 172 supplementation. 173 Deaths from respiratory disease are mostly deaths from exacerbations of COPD which are 174 caused by acute infections in the majority of cases or from acute respiratory infections 175 causing pneumonia. Vitamin D3 is thought to protect from occurrence and poor outcomes of 176 respiratory infections by several mechanisms, including enhanced physical barriers 177 (maintenance of junction integrity), cellular innate immunity, and adaptive immunity (1). 178 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.22.20137299 doi: medRxiv preprint Innate and adaptive immunity are being influenced by sex hormones (12), which may explain 179 the observed interaction of sex and 25(OH)D levels with respiratory disease mortality. 180 According to data from the US-American National Health and Nutrition Survey women have a 181 higher inflammation burden than men (the age-range was 40-90+ years (13) supplementation for patients with COPD, the risk of acute exacerbations was estimated to be 204 reduced by 61% (95% CI 36%-77%) (19). In remarkable consistency with our results, these 205 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 23, 2020. It is worth noting that beneficial effects of vitamin D3 supplementation against manifestation 216 or exacerbation of acute respiratory infection during an epidemic would be expected to go 217 beyond individual protection of those using supplementation, as limiting such manifestation 218 and exacerbation would also be expected to reduce the potential of spread of the disease to 219 other persons and relieve the overload of the medical system by the epidemic. 220 To our knowledge, no previous vitamin D3 supplementation RCTs have addressed mortality 221 from respiratory disease as primary endpoint, and no meta-analysis of results for this specific 222 endpoint have been reported, which most likely reflects the relatively small share of deaths 223 from this endpoint among all deaths. In our cohort of older adults these deaths accounted for 224 5.2% of all deaths. Even though this proportion is expected to be higher during the COVID-225 19 pandemic, the majority of deaths still occur from other diseases, and the summary effect, 226 benefit-harm ratio and cost-effectiveness with respect to all relevant outcomes therefore 227 deserve most careful attention for any general prevention efforts. 228 In that respect, vitamin D3 supplementation appears to be a particularly promising approach, 229 especially for population groups with high prevalence of vitamin D insufficiency or deficiency, 230 such as the elderly and those with severe comorbidities (which essentially coincide with 231 population groups at highest risk of severe course and death from SARS-CoV-2 infection 232 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 23, 2020. In conclusion, our results, along with evidence from meta-analyses from RCTs regarding 254 results of vitamin D3 supplementation on various outcomes, suggest that vitamin D3 255 supplementation could make a major contribution to lowering mortality from respiratory and 256 other diseases during and beyond the COVID-19 pandemic, in particular among women. The 257 Endocrine Society recommends 1,500-2,000 IU vitamin D3/day for adults of any age at high 258 risk for vitamin D deficiency (27). The costs for such supplementation are in the order of 30 € 259 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.22.20137299 doi: medRxiv preprint per person per year, or even half that amount when sufficient vitamin D supply is ensured by 260 carefully dosed sun exposure during the summer months. Along with expected savings from 261 prevented respiratory and other diseases, this would make vitamin D3 supplementation a 262 particularly cost-effective and most likely cost-saving measure, whose currently still widely 263 neglected potential should receive increased attention and should more widely be utilized in 264 the fight against the COVID-19 pandemic and beyond. 265 266 Acknowledgements 267 The ESTHER study was funded by grants from the Saarland state Ministry for Social Affairs, (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 23, 2020. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 23, 2020. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.22.20137299 doi: medRxiv preprint The possible pathophysiology mechanism 326 of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-327 aging The 330 Possible Role of Vitamin D in Suppressing Cytokine Storm and Associated Mortality in 331 COVID-19 Patients Vitamin D Receptor stimulation to reduce 334 Acute Respiratory Distress Syndrome (ARDS) in patients with Coronavirus SARS-CoV-2 335 infections The efficacy of vitamin D therapy for patients with COPD: a 338 meta-analysis of randomized controlled trials Association of Vitamin D 340 Deficiency and Treatment with COVID-19 Incidence medRxiv 2020.05.08 Risk factors of critical & mortal COVID-19 cases: A 343 systematic literature review and meta-analysis Decline of acute coronary 346 syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response 347 causes cardiac collateral damage COVID-19 pandemic will have a long-lasting impact on the quality 349 of cirrhosis care Potential 351 impact of the COVID-19 pandemic on financial toxicity in cancer survivors Immediate 354 and long-term impact of the COVID-19 pandemic on delivery of surgical services Krebs in Deutschland für 358 Evaluation, treatment, and prevention 360 of vitamin D deficiency: an Endocrine Society clinical practice guideline J45 -asthma; n=12, J60-J70 -Lung diseases due to external agents